Comparative Pharmacology
Head-to-head clinical analysis: DYCILL versus PENTIDS 200.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DYCILL versus PENTIDS 200.
DYCILL vs PENTIDS '200'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin G benzathine is a slow-release parenteral formulation of penicillin G that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation, and activating autolytic enzymes.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidation and activating autolytic enzymes.
250 mg orally every 6 hours or 500 mg orally every 12 hours.
Penicillin G benzathine: 1.2 million units intramuscularly as a single dose.
None Documented
None Documented
0.5-1 hour; prolonged in renal impairment (up to 20 hours in severe cases).
0.5-1 hour; prolonged in renal impairment; anuric patients up to 10 hours
Renal: approx. 60-80% unchanged by glomerular filtration and tubular secretion. Biliary/fecal: minor (less than 10%).
Renal: 60-90% unchanged; biliary/fecal: 10-40%
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic